StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note published on Wednesday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Down 14.3 %
Shares of CO stock opened at $1.50 on Wednesday. The firm has a market cap of $182.33 million, a price-to-earnings ratio of 2.34 and a beta of 0.16. The company’s 50 day moving average is $1.44 and its 200 day moving average is $1.35. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50.
Global Cord Blood Company Profile
Featured Stories
- Five stocks we like better than Global Cord Blood
- What is a Low P/E Ratio and What Does it Tell Investors?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- Stock Average Calculator
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- Using the MarketBeat Dividend Tax Calculator
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.